These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8317889)

  • 1. Usefulness of fecal alpha-1-antitrypsin for detection of gastrointestinal bleeding in patients with gastric cancer.
    Saikawa Y; Kubota T; Ogawa S; Shimada A; Shibata S; Furukawa T; Yamamoto T; Kumai K; Yoshino K; Ishibiki K
    Anticancer Res; 1993; 13(3):619-22. PubMed ID: 8317889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal bleeding in infancy: clinical, allergological, and microbiological examination.
    Arvola T; Ruuska T; Keränen J; Hyöty H; Salminen S; Isolauri E
    Pediatrics; 2006 Apr; 117(4):e760-8. PubMed ID: 16585287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
    Kovcić V; Jelić S; Filipović I; Tomasević Z
    Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
    Thomas DW; Sinatra FR; Merritt RJ
    Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of fecal alpha 1-antitrypsin excretion for assessment of inflammatory bowel diseases.
    Becker K; Frieling T; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):65-70. PubMed ID: 9512970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased serum alpha 1-antitrypsin does not produce a rise in fecal alpha 1-antitrypsin in patients with healthy intestines].
    Stufler MH; Ewe K; Gierlasinski B; Prün H; Zutt M
    Z Gastroenterol; 1991 Jan; 29(1):11-5. PubMed ID: 2058223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the protein profile of the Adélé tribe of Togo].
    Tété-Bénissan AC; Duriez P; Parra HJ
    Sante; 2000; 10(4):261-6. PubMed ID: 11111244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a fluorometric method for the quantitative assay of fecal hemoglobin in the dog.
    Boulay JP; Lipowitz AJ; Klausner JS; Ellefson M; Schwartz S
    Am J Vet Res; 1986 Jun; 47(6):1293-5. PubMed ID: 3487999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin: assessment of a rapid test.
    Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
    Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
    Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
    Atalay C; Atalay G; Altinok M
    Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of fecal hemoglobin-haptoglobin complex as a new diagnostic tool of lower gastrointestinal tract diseases].
    Meguro T
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):995-1009. PubMed ID: 7959604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha 1-antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer].
    Dumitraşcu D; Radu D; Stanciu L; Ioniţă A; Petcovici M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):57-61. PubMed ID: 2479968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.